Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site-Reference-Cited by-同舟云学术

Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site

Published:1994-01 Issue:10 Volume:12 Page:953-957
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sakaguchi Masashi,Hirayama Yumiko,Maeda Hiroaki,Matsuo Kazuo,Yamamoto Michitaka,Hirai Kanji

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Marek's disease, prevention and control;Witter,1988

2. Marek's disease vaccination strategies using vaccines made from three avian herpesvirus serotypes;de Boer,1988

3. Attenuated revertant serotype 1 Marek's disease viruses — safety and protective efficacy;Witter;Avian Dis.,1991

4. Recent developments in the prevention and control of Marek's disease;Witter,1992

5. Molecular biology of Marek's disease virus. A review;Hirai,1988

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HVT-vectored H7 vaccine protects chickens from lethal infection with the highly pathogenic H7N9 Avian inﬂuenza virus;Veterinary Microbiology;2023-10

2. The alphaherpesvirus conserved pUS10 is important for natural infection and its expression is regulated by the conserved Herpesviridae protein kinase (CHPK);PLOS Pathogens;2023-02-07

3. The alphaherpesvirus conserved pUS10 is important for natural infection and its expression is regulated by the conservedHerpesviridaeprotein kinase (CHPK);2022-11-01

4. Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens;Virus Research;2019-09

5. Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine;Archives of Virology;2016-12-09